When incompatible blood reaches a patient, the investigation should trace two identities at once: the patient and the blood component. A mismatch can begin during specimen collection, compatibility testing, blood-bank release, transport, bedside verification, or administration. The records must show where those paths separated.
Start with the order and pretransfusion specimen
Preserve the transfusion order, indication, consent, prior type-and-screen results, antibody history, and pretransfusion laboratory values. For the specimen, identify the collector, collection time, bedside labeling method, tube identifiers, accession number, and every electronic scan or manual entry.
Retain the original blood-bank data, including ABO and Rh testing, antibody screening, crossmatch results, unit number, component type, expiration, special processing, and issue log. Electronic audit records may show user names, corrections, warning messages, and overrides that are absent from a printed report.
Follow the unit from the blood bank to the bedside
Document who released, transported, received, stored, and returned the unit. Temperature and storage records may matter if the unit waited outside controlled storage. At the bedside, identify each person who checked the wristband, patient statement, order, unit label, compatibility tag, and expiration information.
Barcode systems can help reconstruct the sequence, but an accepted scan does not establish that every physical item matched the screen. Preserve scanner logs, device identity, downtime records, workarounds, overrides, and any later edits.
Reconstruct the transfusion and reaction
Align the start time, baseline vital signs, monitoring entries, infusion rate, volume delivered, symptom onset, stop time, clinician notification, and treatment. Preserve the bag, tubing, labels, post-reaction blood and urine specimens, repeat typing, hemolysis testing, direct antiglobulin testing, and blood-bank reaction workup.
The reaction record should include fever, chills, pain, breathing difficulty, hypotension, bleeding, urine changes, and the patient’s laboratory course. It should also consider other causes, such as an allergic reaction, contamination, circulatory overload, or the underlying illness.
Separate the error point from the injury
A mislabeled specimen, incorrect blood-bank result, wrong unit release, patient transport error, or failed bedside check may produce the same final mismatch through different mechanisms. Each step may involve different people, policies, equipment, and organizations. The investigation should identify the specific break rather than describing the event only as a transfusion mistake.
FDA explains that a computer crossmatch is used to determine compatibility between a donor component and the intended recipient. FDA also maintains transfusion-fatality reporting information. Regulatory reporting and safety materials are important evidence to preserve, but they do not replace the underlying patient, laboratory, and unit records.
Document short-term and lasting harm
Acute hemolysis can affect the kidneys, circulation, clotting, and other organs. Preserve intensive-care records, dialysis, transfusions given to correct the event, procedures, and follow-up testing. Expert review should distinguish injury caused by incompatibility from the illness that prompted the transfusion.
A Louisiana medical malpractice lawyer can coordinate transfusion-medicine and systems review. The firm’s discussion of medical malpractice and wrongful-death claims and guide to preserving complete medical records offer additional context.
Editorial & Legal Accuracy Notice (Louisiana)
Sources checked: September 24, 2026
Compatibility error, professional responsibility, clinical response, causation, and damages require patient-specific medical and legal review.